Limited disease small cell lung cancer: alternating combination of doxorubicin, etoposide, ifosfamide and hyperfractionated radiotherapy. Final results of a multicentric pilot study for the Groupe Lyonnias d'Oncologie Thoracique (GLOT) (Q72148757)
Jump to navigation
Jump to search
scientific article published on 01 October 1993
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Limited disease small cell lung cancer: alternating combination of doxorubicin, etoposide, ifosfamide and hyperfractionated radiotherapy. Final results of a multicentric pilot study for the Groupe Lyonnias d'Oncologie Thoracique (GLOT) |
scientific article published on 01 October 1993 |
Statements
Limited disease small cell lung cancer: alternating combination of doxorubicin, etoposide, ifosfamide and hyperfractionated radiotherapy. Final results of a multicentric pilot study for the Groupe Lyonnias d'Oncologie Thoracique (GLOT) (English)
V Trillet-Lenoir
F Mornex
F Chauvin
P Fournel
A Voloch
M Perol
E Laennec
D Piperno
J Boyer